| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000240401.4 |
Ponatinib |
Brain lower grade glioma |
0.011836011 |
Resistant |
| ENSG00000240401.4 |
Ponatinib |
Colon adenocarcinoma |
0.006525335 |
Sensitive |
| ENSG00000240401.4 |
Ponatinib |
Stomach adenocarcinoma |
0.041362484 |
Sensitive |
| ENSG00000240401.4 |
Ponatinib |
Esophageal cancer |
0.043800377 |
Resistant |
| ENSG00000240401.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.025327834 |
Resistant |